Indian Journal of Nuclear Medicine

INTERESTING IMAGE
Year
: 2022  |  Volume : 37  |  Issue : 3  |  Page : 277--278

F-18 PSMA uptake in male breast cancer during restaging evaluation of carcinoma prostate


Anand Zade1, Shishir Shetty2, Asawari Ambekar3, Makarand Karpe2 
1 Department of Nuclear Medicine, Apollo Hospitals, Sector 23, CBD Belapur, Navi Mumbai, India
2 Department of Oncosurgery, Apollo Hospitals, Sector 23, CBD Belapur, Navi Mumbai, India
3 Department of Pathology, Apollo Hospitals, Sector 23, CBD Belapur, Navi Mumbai, India

Correspondence Address:
Dr. Anand Zade
Department of Nuclear Medicine, Apollo Hospitals, Sector 23, CBD Belapur, Navi Mumbai - 400 614, Maharashtra
India

Fluorine-18 prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography scan is widely used for restaging of prostate cancer. We present a case where false-positive PSMA uptake was seen in metachronous carcinoma breast during restaging workup of carcinoma prostate.


How to cite this article:
Zade A, Shetty S, Ambekar A, Karpe M. F-18 PSMA uptake in male breast cancer during restaging evaluation of carcinoma prostate.Indian J Nucl Med 2022;37:277-278


How to cite this URL:
Zade A, Shetty S, Ambekar A, Karpe M. F-18 PSMA uptake in male breast cancer during restaging evaluation of carcinoma prostate. Indian J Nucl Med [serial online] 2022 [cited 2023 Jan 27 ];37:277-278
Available from: https://www.ijnm.in/article.asp?issn=0972-3919;year=2022;volume=37;issue=3;spage=277;epage=278;aulast=Zade;type=0